Pharm Company: * TEVA PHARMS USA INC
Category: Cancer

Pralatrexate, sold under the brand name Folotyn, is a medication used for the treatment of relapsed or refractory peripheral T-cell lymphoma (PTCL).[1][2] Pralatrexate was approved for medical use in the United States in September 2009, as the first treatment for Peripheral T-cell Lymphoma (PTCL), an often aggressive type of non-Hodgkins lymphoma.[2][3] Contents 1 Medical uses 2 Mechanism 3 Discovery 4 Society and culture 4.1... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Pralatrexate 20 mg/ml Intravenous Injection
NDC: 65219-550
Fresenius Kabi USA, LLC
Pralatrexate 40 mg/2ml Intravenous Injection
NDC: 65219-552
Fresenius Kabi USA, LLC

Related Brands

Drugs with the same active ingredients